Skip to search formSkip to main contentSkip to account menu

proxibarbal

Known as: 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-hydroxypropyl)-5-(2-propenyl)-, proxybarbital 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (3)

AxeenIpronalVasalgin

Broader (2)

BarbituratesHypnotics and Sedatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Pharmacokinetics ofl4C-2-allophanyl-2-allyl -gamma-valerolactone: a prodrug of proxibarbal in rats
SummaryThe pharmacokinetics and metabolism of 2-allophanyl-2-allyl-gamma-valerolactone (AAV) was studied in rats. AAV was… 
1992
1992
[Peripheral thrombopenia secondary to proxibarbal therapy].
1989
1989
[A controlled trial of prevention of recurrence of gastroduodenal ulcers with proxybarbital].
During 3 years, the usefulness of proxibarbal (Ipronal "Polfa") for gastro-duodenal ulcer recurrences prophylaxis has been studie… 
1988
1988
[Kinetics of the changes in the proxybarbital level after its oral and intravenous administration in a monocompartmental model in humans].
1987
1987
[Treatment of psycho-neuro-autonomic disorders of menopause: contribution of veralipride compared with a barbiturate sedative (proxibarbal)].
1984
1984
Isomerisation and urinary excretion of proxibarbal and valofan in man; a preliminary study
SummaryProxibarbal and valofan are tautomeric drμgs which interconvert rapidly in solution. In the present study, the urinary… 
1984
1984
[Spectrophotometric and spectrofluorometric study of barbituric acid and thiobarbituric acid derivatives. I. General spectrophotometric and spectrofluorometric properties of barbituric acid…
1984
1984
[Development of proxibarbal blood levels. The role of various elimination processes].
Half-lives of barbiturates are short when their lipid solubility is high but long when they are less lipophilic. Infection of… 
1980
1980
Metabolic investigations of proxibarbal [5-allyl-5-(2-hydroxypropyl)barbituric acid] in vitro.
1980
1980
Preventive Treatment of Migraine with Enzyme Induction by Proxibarbal in a “Double‐Blind” Trial
SYNOPSIS 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)